Related content

A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine

By Bartolini Marco  

The Journal of Headache and Pain, Vol. 12, Iss. 3, 2011-06 ,pp. : 361-368

Springer Publishing Company

Access to resources Recommend Favorite

A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine

By Savi Lidia   Omboni Stefano   Lisotto Carlo   Zanchin Giorgio   Ferrari Michel   Zava Dario   Pinessi Lorenzo  

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 219-226

Springer Publishing Company

Access to resources Recommend Favorite

A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine

By Dahlöf Carl   Jones Martin   Davis Kim   Loftus Jane   Salonen Reijo  

The Journal of Headache and Pain, Vol. 5, Iss. 2, 2004-08 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Oral contraceptives in migraine therapy

By Allais Gianni   Castagnoli Gabellari Ilaria   De Lorenzo Cristina   Mana Ornella   Benedetto Chiara  

Neurological Sciences, Vol. 32, Iss. 1, 2011-05 ,pp. : 135-139

Springer Publishing Company

Access to resources Recommend Favorite

Identifying Patients Who Require a Change in Their Current Acute Migraine Treatment: The Migraine Assessment of Current Therapy (Migraine-ACT) Questionnaire

By Dowson A. J.   Tepper S. J.   Baos V.   Baudet F.   D'Amico D.   Kilminster S.  

Headache Care, Vol. 2, Iss. 1, 2004-03 ,pp. : 5-10

Informa Healthcare

Access to resources Recommend Favorite